In reply

Journal of Clinical Oncology

Volumn 26, Issue 21, 2008, Pages 3657-3658

  Pachmann, Katharina ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; EPITHELIAL CELL ADHESION MOLECULE; EPITOPE; TAXANE DERIVATIVE;

BONE MARROW METASTASIS; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER GROWTH; CANCER PATIENT; CANCER REGRESSION; CANCER STAGING; EPITHELIUM TUMOR; HUMAN; LETTER; LYMPH NODE METASTASIS; MASTECTOMY; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; TREATMENT RESPONSE; TUMOR CELL; TUMOR VOLUME;

EID: 51349113451     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2008.18.0927     Document Type: Letter

References (13)

1. Pachmann K, Camara O, Kavallaris A, et al: Monitoring the response of circulating epithelial tumor cells to adjuvant chemotherapy in breast cancer allows detection of patients at risk of early relapse. J Clin Oncol 26:1208-1215, 2008
2. Meng S, Tripathy D, Frenkel EP, et al: Circulating tumor cells in patients with breast cancer dormancy. Clin Cancer Res 10:8152-8162, 2004
3. Terstappen LW, Rao C, Gross S, et al: Peripheral blood tumor cell load reflects the clinical activity of the disease in patients with carcinoma of the breast. Int J Oncol 17:573-578, 2000
4. Racila E, Euhus D, Weiss AJ, et al: Detection and characterization of carcinoma cells in the blood. Proc Natl Acad Sci U S A 95:4589-4594, 1998
5. GoenAM, Yaziji H, Battifora H: Correspondence Re: Varma et al: Effect of Formalin Fixation and Epitope Retrieval Techniques on antibody 34βE12 Immunostaining of Prostatic Tissues. Mod Pathol 13:834-835, 2000
6. Rao CG, Chianese D, Doyle GV, et al: Expression of epithelial cell adhesion molecule in carcinoma cells present in blood and primary and metastatic tumors. Int J Oncol 27:49-57, 2005
7. Pachmann K, Clement JH, Schneider CP, et al: Standardized quantification of circulating peripheral tumor cells from lung and breast cancer. Clin Chem Lab Med 43:617-627, 2005
8. Lobodasch K, Dengler R, Fröhlich F, et al: Quantification of circulating tumour cells for monitoring of adjuvant therapy in breast cancer: An increase in cell number at completion of therapy is a predictor of early relapse. The Breast 16:211-218, 2007
9. Pachmann K, Dengler R, Lobodasch K, et al: Quantification of circulating tumor cells (CETC) for monitoring of adjuvant therapy in breast cancer. An increase in cell number at completion of therapy may develop as an indicator of early relapse. J Cancer Res Clin Oncol 134:59-65, 2008
10. Cristofanilli M, Budd GT, Ellis MJ, et al: Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 351:781-791, 2004
11. Nagrath S, Sequist LV, Maheswaran S, et al: Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature 450:1168-1169, 2007
12. Camara O, Rengsberger M, Egbe A, et al: The relevance of circulating epithelial tumour cells (CETC) for therapy monitoring during neoadjuvant (primary systemic) chemotherapy in breast cancer. Ann Oncol 18:1484-1492, 2007
13. Brackstone M, Townson JL, Chambers AF: Tumour dormancy in breast cancer: An update. Breast Cancer Res 9:208, 2007